CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Phenylbutazone

保泰松 杂质对照品Phenylbutazone Impurities

EP46 个杂质条目46 impurity entries

本页汇总 保泰松 的 46 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Phenylbutazone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 保泰松(Phenylbutazone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSolid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds
    Journal of chromatography · 1992 · Caturla MC, Cusido E  ·  PMID 1429991  ·  DOI
  2. 杂质研究Impurity studiesSpecimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds
    Pharmaceutisch weekblad. Scientific edition · 1986 · Franssen MJ et al.  ·  PMID 3763367  ·  DOI
  3. 杂质研究Impurity studiesSimultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography
    Journal of chromatography. B, Biomedical sciences and applications · 2000 · Grippa E et al.  ·  PMID 10778922  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisStudies on the effect of phenylbutazone and salicylate on the rates of synthesis of albumin and acute-phase alpha 1-acid glycoprotein by rat liver slices
    Biochemical medicine · 1980 · Jamieson JC, Kutryk M  ·  PMID 7417236  ·  DOI
  • 合成方法Synthesis[The action of phenylbutazone and sodium salicylate on the glucosamine-6-phosphate synthesis of the gastric mucosa of rats]
    Archives internationales de pharmacodynamie et de therapie · 1968 · Perrey KH  ·  PMID 5716974

保泰松 —— 原料药与杂质对照品Phenylbutazone — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Phenylbutazone structure
EP原料药 APIAPI
保泰松Phenylbutazone
Phenylbutazone
CAS No.50-33-9
Chemical FormulaC19H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 1 (Phenylbutazone EP Impurity A) structure
EPA
保泰松杂质1(保泰松EP杂质A)Phenylbutazone Impurity 1 (Phenylbutazone EP Impurity A)
Phenylbutazone Impurity 1 (Phenylbutazone EP Impurity A)
CAS No.3583-64-0
Chemical FormulaC19H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 2 (Phenylbutazone EP Impurity B) structure
EPB
保泰松杂质2(保泰松EP杂质B)Phenylbutazone Impurity 2 (Phenylbutazone EP Impurity B)
Phenylbutazone Impurity 2 (Phenylbutazone EP Impurity B)
CAS No.16860-43-8
Chemical FormulaC19H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 4 (Phenylbutazone EP Impurity D) structure
EPD
保泰松杂质4(保泰松EP杂质D)Phenylbutazone Impurity 4 (Phenylbutazone EP Impurity D)
Phenylbutazone Impurity 4 (Phenylbutazone EP Impurity D)
CAS No.103-33-3
Chemical FormulaC12H10N2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 6 structure
6
保泰松杂质6Phenylbutazone Impurity 6
Phenylbutazone Impurity 6
CAS No.30923-77-4
Chemical FormulaC18H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 7 structure
7
保泰松杂质7Phenylbutazone Impurity 7
Phenylbutazone Impurity 7
CAS No.693-57-2
Chemical FormulaC12H25NO2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 8 structure
8
保泰松杂质8Phenylbutazone Impurity 8
Phenylbutazone Impurity 8
CAS No.4761-26-6
Chemical FormulaC11H18O5
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 9 structure
9
保泰松杂质9Phenylbutazone Impurity 9
Phenylbutazone Impurity 9
CAS No.568-76-3
Chemical FormulaC19H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 10 structure
10
保泰松杂质10Phenylbutazone Impurity 10
Phenylbutazone Impurity 10
CAS No.853-34-9
Chemical FormulaC19H18N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 11 structure
11
保泰松杂质11Phenylbutazone Impurity 11
Phenylbutazone Impurity 11
CAS No.7796-23-8
Chemical FormulaC13H22O6
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 12 structure
12
保泰松杂质12Phenylbutazone Impurity 12
Phenylbutazone Impurity 12
CAS No.2210-63-1
Chemical FormulaC13H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 13 structure
13
保泰松杂质13Phenylbutazone Impurity 13
Phenylbutazone Impurity 13
CAS No.615-08-7
Chemical FormulaC10H6O5
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 14 structure
14
保泰松杂质14Phenylbutazone Impurity 14
Phenylbutazone Impurity 14
CAS No.1093-68-1
Chemical FormulaC18H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 15 structure
15
保泰松杂质15Phenylbutazone Impurity 15
Phenylbutazone Impurity 15
CAS No.16418-56-7
Chemical FormulaC14H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 16 structure
16
保泰松杂质16Phenylbutazone Impurity 16
Phenylbutazone Impurity 16
CAS No.1732-61-2
Chemical FormulaC13H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 17 structure
17
保泰松杂质17Phenylbutazone Impurity 17
Phenylbutazone Impurity 17
CAS No.26598-82-3
Chemical FormulaC20H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 18 structure
18
保泰松杂质18Phenylbutazone Impurity 18
Phenylbutazone Impurity 18
CAS No.3474-99-5
Chemical FormulaC30H22N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 19 structure
19
保泰松杂质19Phenylbutazone Impurity 19
Phenylbutazone Impurity 19
CAS No.54719-43-6
Chemical FormulaC17H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 20 structure
20
保泰松杂质20Phenylbutazone Impurity 20
Phenylbutazone Impurity 20
CAS No.6136-32-9
Chemical FormulaC18H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 21 structure
21
保泰松杂质21Phenylbutazone Impurity 21
Phenylbutazone Impurity 21
CAS No.37606-80-7
Chemical FormulaC20H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 22 structure
22
保泰松杂质22Phenylbutazone Impurity 22
Phenylbutazone Impurity 22
CAS No.32060-76-7
Chemical FormulaC22H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 23 structure
23
保泰松杂质23Phenylbutazone Impurity 23
Phenylbutazone Impurity 23
CAS No.129-20-4
Chemical FormulaC19H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 24 structure
24
保泰松杂质24Phenylbutazone Impurity 24
Phenylbutazone Impurity 24
CAS No.78945-52-5
Chemical FormulaC21H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 25 structure
25
保泰松杂质25Phenylbutazone Impurity 25
Phenylbutazone Impurity 25
CAS No.30720-28-6
Chemical FormulaC20H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 26 structure
26
保泰松杂质26Phenylbutazone Impurity 26
Phenylbutazone Impurity 26
CAS No.6082-56-0
Chemical FormulaC18H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 27 structure
27
保泰松杂质27Phenylbutazone Impurity 27
Phenylbutazone Impurity 27
CAS No.6139-79-3
Chemical FormulaC17H14N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 28 structure
28
保泰松杂质28Phenylbutazone Impurity 28
Phenylbutazone Impurity 28
CAS No.346446-42-2
Chemical FormulaC27H27N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 2-d9 structure
2-D9
保泰松杂质2-d9Phenylbutazone Impurity 2-d9
Phenylbutazone Impurity 2-d9
CAS No.1246819-23-7
Chemical FormulaC19H11D9N2O3
Purity>95%询价On request
Phenylbutazone Impurity 29 structure
29
保泰松杂质29Phenylbutazone Impurity 29
Phenylbutazone Impurity 29
CAS No.32060-75-6
Chemical FormulaC22H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 30 structure
30
保泰松杂质30Phenylbutazone Impurity 30
Phenylbutazone Impurity 30
CAS No.346446-44-4
Chemical FormulaC26H31N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 31 structure
31
保泰松杂质31Phenylbutazone Impurity 31
Phenylbutazone Impurity 31
CAS No.1775-34-4
Chemical FormulaC19H29N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 32 structure
32
保泰松杂质32Phenylbutazone Impurity 32
Phenylbutazone Impurity 32
CAS No.14845-06-8
Chemical FormulaC17H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 33 structure
33
保泰松杂质33Phenylbutazone Impurity 33
Phenylbutazone Impurity 33
CAS No.37606-83-0
Chemical FormulaC18H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 34 structure
34
保泰松杂质34Phenylbutazone Impurity 34
Phenylbutazone Impurity 34
CAS No.2515-68-6
Chemical FormulaC22H23N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 35 structure
35
保泰松杂质35Phenylbutazone Impurity 35
Phenylbutazone Impurity 35
CAS No.62257-56-1
Chemical FormulaC18H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 36 structure
36
保泰松杂质36Phenylbutazone Impurity 36
Phenylbutazone Impurity 36
CAS No.953-01-5
Chemical FormulaC12H10Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 37 structure
37
保泰松杂质37Phenylbutazone Impurity 37
Phenylbutazone Impurity 37
CAS No.532-82-1
Chemical FormulaC12H12N4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 38 structure
38
保泰松杂质38Phenylbutazone Impurity 38
Phenylbutazone Impurity 38
CAS No.20222-80-4
Chemical FormulaC10H8N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 39 structure
39
保泰松杂质39Phenylbutazone Impurity 39
Phenylbutazone Impurity 39
CAS No.41097-65-8
Chemical FormulaC13H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 40 structure
40
保泰松杂质40Phenylbutazone Impurity 40
Phenylbutazone Impurity 40
CAS No.1086224-41-0
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 41 structure
41
保泰松杂质41Phenylbutazone Impurity 41
Phenylbutazone Impurity 41
CAS No.1669422-54-1
Chemical FormulaC15H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 42 structure
42
保泰松杂质42Phenylbutazone Impurity 42
Phenylbutazone Impurity 42
CAS No.588-64-7
Chemical FormulaC13H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 43 structure
43
保泰松杂质43Phenylbutazone Impurity 43
Phenylbutazone Impurity 43
CAS No.10604-20-3
Chemical FormulaC15H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 44 structure
44
保泰松杂质44Phenylbutazone Impurity 44
Phenylbutazone Impurity 44
CAS No.109411-83-8
Chemical FormulaC15H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 45 structure
45
保泰松杂质45Phenylbutazone Impurity 45
Phenylbutazone Impurity 45
CAS No.873987-61-2
Chemical FormulaC14H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 48 structure
48
保泰松杂质48Phenylbutazone Impurity 48
Phenylbutazone Impurity 48
CAS No.210536-89-3
Chemical FormulaC21H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Phenylbutazone Impurity 51 structure
51
保泰松杂质51Phenylbutazone Impurity 51
Phenylbutazone Impurity 51
CAS No.2411967-06-9
Chemical FormulaC14H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

保泰松 —— 研究文献与合成路线Phenylbutazone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 保泰松 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Phenylbutazone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability-indicating assay for phenylbutazone: high-performance liquid chromatographic determination of hydrazobenzene and azobenzene in degraded aqueous phenylbutazone solutions
    Fabre H, Hussam-Eddine N, Mandrou B · Journal of pharmaceutical sciences · 1984 · 被引 5cited 5
  2. Pattern of phenylbutazone degradation
    Awang DV, Vincent A, Matsui F · Journal of pharmaceutical sciences · 1973 · 被引 24cited 24
  3. Identification of degradation products in a phenylbutazone tablet formulation
    Matsui F, Robertson DL, Poirier MA, et al. · Journal of pharmaceutical sciences · 1980 · 被引 6cited 6
  4. [Chemical characteristic of degradation products of drugs. IV. Mechanism of degradation of phenylbutazone in pharmaceutical preparations]
    Pawelczyk E, Wachowiak R · Acta poloniae pharmaceutica · 1969 · 被引 4cited 4
  5. Mass spectral and pyrolytic behavior of the two main products of phenylbutazone degradation: simulation of unusual mass spectral fragmentation
    Awang DV, Vincent A · Journal of pharmaceutical sciences · 1976 · 被引 3cited 3
  6. Photochemical fluorimetric analysis of phenylbutazone and its degradation products
    Fricoteaux R, Aaron JJ, Quaglia MG · Journal of pharmaceutical and biomedical analysis · 1989 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. Hydroxy phenylbutazone derivatives and their preparation
    RAHTZ DIETER, KOCH HENNING, GERHARDS ERICH · 公开号 US3968219US3968219 · 1976

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

保泰松 杂质谱研究要点Phenylbutazone — impurity profiling notes

下面这些是拿到 保泰松 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Phenylbutazone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances